August 2020 – Proactive Investors: One2One Virtual Conference

https://youtu.be/HjMglJPChJA

July 2020 – Proactive Investors: ReNeuron’s Michael Hunt says key focus now is to build dataset for retinal disease study

Preliminary Results Presentation for the year ended 31 March 2020

To view the presentation of the preliminary results for the year ended 31 March 2020 please click here.

Association for research in vision and ophthalmology (ARVO) annual meeting 2019 : Jason Commander presentation

To view the presentation please click here…

Proactive Investors : “ReNeuron Group agrees £80mln cell therapy licensing deal for China”

https://www.youtube.com/watch?v=H3Ny1KbHusg

Proactive Investors ‘ReNeuron provides encouraging update to phase II eye disease trial’

https://youtu.be/ADBu4Uy7ZZ0

OIS: Ophthalmology Innovation & Investment – ReNeuron using hRPCs to treat inherited retinal degenerative diseases

OIS: Ophthalmology Innovation & Investment – ReNeuron using hRPCs to treat inherited retinal degenerative diseases

2017 AGM Trading Update – Shareholder Presentation

September 2017: Please click here to see the slides accompanying the AGM Trading Update presentation.

Proactive Investors : CFO ‘very pleased’ to be awarded £1.8m grant

To view the full article click here…